Fig. 3From: Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinomaDetection of CD276 in tissue samples by immunohistochemistry. Representative tissue samples of benign urothelium (a), low expressing tumor tissue (b) and high expressing tumor tissue (c) were assessed for expression of CD276 on a tissue microarray by immunohistochemistry. Sections were counterstained with hematoxylin and eosin to visualize tissue structure. Size bars = 100 μmBack to article page